Nisa Investment Advisors, LLC Coherus Bio Sciences, Inc. Transaction History

Nisa Investment Advisors, LLC

$25.4 Billion
Q3 2025

A detailed history of Nisa Investment Advisors, LLC transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 574 shares of CHRS stock, worth $1,027. This represents 0.0% of its overall portfolio holdings.

Number of Shares

574

Previous 599 4.17%

Holding current value

$1,027

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 23, 2025	SELL	$0.75 - $1.7 $18 - $42	-25 Reduced 4.17%	574 $0
Q2 2025 Jul 31, 2025	SELL	$0.72 - $1.12 $2,941 - $4,576	-4,086 Reduced 87.21%	599 $0
Q1 2025 Apr 30, 2025	BUY	$0.81 - $1.66 $6 - $13	8 Added 0.17%	4,685 $3,000
Q4 2024 Jan 17, 2025	BUY	$0.67 - $1.71 $444 - $1,133	663 Added 16.52%	4,677 $6,000
Q3 2024 Oct 24, 2024	SELL	$0.99 - $1.8 $16,476 - $29,957	-16,643 Reduced 80.57%	4,014 $4,000
Q2 2024 Jul 19, 2024	BUY	$1.58 - $2.51 $31,460 - $49,979	19,912 Added 2672.75%	20,657 $35,000
Q1 2024 May 01, 2024	BUY	$2.02 - $3.14 $272 - $423	135 Added 22.13%	745 $1,000
Q4 2023 Jan 25, 2024	SELL	$1.59 - $3.85 $166 - $404	-105 Reduced 14.69%	610 $2,000
Q3 2023 Nov 02, 2023	BUY	$3.74 - $5.45 $205 - $299	55 Added 8.33%	715 $2,000
Q2 2023 Aug 11, 2023	BUY	$3.79 - $8.3 $94 - $207	25 Added 3.94%	660 $2,000
Q1 2023 May 02, 2023	BUY	$5.89 - $10.52 $147 - $263	25 Added 4.1%	635 $4,000
Q4 2022 Feb 02, 2023	SELL	$5.69 - $10.07 $398 - $704	-70 Reduced 10.29%	610 $5,000
Q3 2022 Nov 07, 2022	BUY	$7.17 - $13.87 $501 - $970	70 Added 11.48%	680 $6,000
Q2 2022 Aug 03, 2022	SELL	$5.86 - $13.23 $160,974 - $363,428	-27,470 Reduced 97.83%	610 $4,000
Q1 2022 Apr 29, 2022	SELL	$10.92 - $16.41 $2,730 - $4,102	-250 Reduced 0.88%	28,080 $363,000
Q4 2021 Feb 03, 2022	SELL	$15.81 - $18.99 $28,932 - $34,751	-1,830 Reduced 6.07%	28,330 $350,000
Q2 2021 Aug 06, 2021	BUY	$12.95 - $15.41 $27,195 - $32,361	2,100 Added 7.48%	30,160 $417,000
Q4 2020 Jan 25, 2021	BUY	$16.56 - $18.94 $14,075 - $16,099	850 Added 3.12%	28,060 $488,000
Q3 2020 Oct 20, 2020	BUY	$17.41 - $19.89 $40,043 - $45,747	2,300 Added 9.23%	27,210 $499,000
Q1 2020 Apr 17, 2020	BUY	$11.67 - $22.53 $1,400 - $2,703	120 Added 0.48%	24,910 $404,000
Q3 2019 Oct 17, 2019	BUY	$16.3 - $23.37 $2,934 - $4,206	180 Added 0.73%	24,790 $502,000
Q4 2018 Jan 17, 2019	SELL	$8.65 - $16.28 $34,600 - $65,120	-4,000 Reduced 13.98%	24,610 $223,000
Q3 2018 Oct 16, 2018	BUY	$14.45 - $20.25 $4,479 - $6,277	310 Added 1.1%	28,610 $472,000
Q4 2017 Jan 12, 2018	BUY	$8.35 - $14.4 $236,305 - $407,520	28,300	28,300 $249,000

Others Institutions Holding CHRS

# of Institutions

122

Shares Held

57.9M

Call Options Held

89.3K

Put Options Held

31K

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $139M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Account

Nisa Investment Advisors, LLC Coherus Bio Sciences, Inc. Transaction History